autosomal dominant polycystic kidney disease

Showing 1 - 25 of 46

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis, AHL Amyloidosis Trial in Bristol

Recruiting
  • Adenine Phosphoribosyltransferase Deficiency
  • +83 more
    • Bristol, South West, United Kingdom
      Zoe Plummer
    Sep 26, 2023

    Autosomal Dominant Polycystic Kidney Disease, Chronic Kidney Diseases Trial in New Taipei City, Taipei (Atorvastatin 20 Mg Oral

    Enrolling by invitation
    • Autosomal Dominant Polycystic Kidney Disease
    • Chronic Kidney Diseases
    • Atorvastatin 20 Mg Oral Tablet
    • Sodium Bicarbonate 600 Mg Oral Tablet
    • New Taipei City, Taiwan
    • +2 more
    May 19, 2023

    Autosomal Dominant Polycystic Kidney Disease Trial in Australia (Metformin XR, Control)

    Not yet recruiting
    • Autosomal Dominant Polycystic Kidney Disease
    • Metformin XR
    • Control
    • Sydney, New South Wales, Australia
    • +3 more
    Nov 9, 2022

    Autosomal Dominant Polycystic Kidney Disease Trial in Rochester

    Recruiting
    • Autosomal Dominant Polycystic Kidney Disease
      • Rochester, Minnesota
        Mayo Clinic
      Aug 15, 2022

      Intrarenal Microvasculature in ADPKD

      Recruiting
      • Autosomal Dominant Polycystic Kidney Disease
        • Rochester, Minnesota
          Mayo Clinic
        Aug 15, 2022

        Autosomal Dominant Polycystic Kidney Disease (ADPKD)

        Recruiting
        • Autosomal Dominant Polycystic Kidney Disease
          • Rochester, Minnesota
            Mayo Clinic in Rochester
          Aug 15, 2022

          Endothelial Function and Oxidative Stress in Normotensive ADPKD

          Completed
          • Autosomal Dominant Polycystic Kidney Disease
            • Rochester, Minnesota
              Mayo Clinic
            Aug 15, 2022

            Uncontrolled Hypertension, Autosomal Dominant Polycystic Kidney Disease, Renal Denervation Trial in Erlangen (Renal denervation)

            Recruiting
            • Uncontrolled Hypertension
            • +2 more
            • Renal denervation
            • Erlangen, Germany
              University Hospital FAU Erlangen-Nürnberg
            Jul 11, 2022

            Autosomal Dominant Polycystic Kidney Disease Trial in Ranica (Tolvaptan, Octreotide LAR, Placebo)

            Completed
            • Autosomal Dominant Polycystic Kidney Disease
            • Ranica, Bergamo, Italy
              CRC per le Malattie Rare Aldo e Cele Daccò
            Mar 10, 2022

            Autosomal Dominant Polycystic Kidney Disease, Nephrogenic Diabetes Insipidus, Acquired Nephrogenic Diabetes Insipidus Trial in

            Recruiting
            • Autosomal Dominant Polycystic Kidney Disease
            • +3 more
            • Rochester, Minnesota
              Mayo Clinic Rochester
            Feb 14, 2022

            Autosomal Dominant Polycystic Kidney Disease Trial in Los Angeles (Pravastatin, sodium citrate)

            Enrolling by invitation
            • Autosomal Dominant Polycystic Kidney Disease
            • Los Angeles, California
              Keck School of Medicine of University of Southern California
            Jan 24, 2022

            Autosomal Dominant Polycystic Kidney Disease Trial in Worldwide (Placebo, GLPG2737)

            Active, not recruiting
            • Autosomal Dominant Polycystic Kidney Disease
            • Brussels, Belgium
            • +19 more
            Nov 23, 2021

            Autosomal Dominant Polycystic Kidney Disease Trial in New York

            Active, not recruiting
            • Autosomal Dominant Polycystic Kidney Disease
              • New York, New York
                Weill Cornell Medicine
              Jul 29, 2021

              Autosomal Dominant Polycystic Kidney Disease Trial in United States (Lixivaptan)

              Completed
              • Autosomal Dominant Polycystic Kidney Disease
              • Los Angeles, California
              • +12 more
              Nov 25, 2020

              Autosomal Dominant Polycystic Kidney Disease Trial in Mitaka (Tolvaptan)

              Unknown status
              • Autosomal Dominant Polycystic Kidney Disease
              • Mitaka, Tokyo, Japan
                Kyorin University Hospital
              Jun 3, 2020

              Somatostatin Analogs, Polycystic Liver Disease, Autosomal Dominant Polycystic Kidney Disease Trial in Rochester (Pasireotide

              Completed
              • Somatostatin Analogs
              • +3 more
              • Pasireotide LAR
              • Placebo
              • Rochester, Minnesota
                Mayo Clinic
              Apr 30, 2020

              ADPKD Alterations in Hepatic Transporter Function

              Completed
              • ADPKD
              • +2 more
                • Chapel Hill, North Carolina
                  University of North Carolina
                Mar 23, 2020

                ADPKD and Peritoneal Dialysis: How Anticipate Peritoneal

                Completed
                • Autosomal Dominant Polycystic Kidney Disease
                • Intra-peritoneal pressure
                • Reims, France
                  Damien JOLLY
                May 29, 2019

                Quality of Life, Treatment Preference and Satisfaction of ADPKD

                Unknown status
                • Autosomal Dominant Polycystic Kidney Disease
                  • Vienna, Austria
                  • +25 more
                  Apr 9, 2019

                  Autosomal Dominant Polycystic Kidney Disease Trial (Vessix)

                  Withdrawn
                  • Autosomal Dominant Polycystic Kidney Disease
                  • Vessix
                  • (no location specified)
                  Apr 1, 2019

                  Autosomal Dominant Polycystic Kidney Disease Trial in Groningen (Tolvaptan)

                  Completed
                  • Autosomal Dominant Polycystic Kidney Disease
                  • Groningen, Netherlands
                    University Medical Center Groningen
                  Feb 20, 2019

                  Autosomal Dominant Polycystic Kidney Disease Trial in Cambridge (High water intake, Ad libitum water intake)

                  Completed
                  • Autosomal Dominant Polycystic Kidney Disease
                  • High water intake
                  • Ad libitum water intake
                  • Cambridge, United Kingdom
                    Cambridge University Hospitals NHS Foundation Trust
                  Jan 13, 2019

                  Autosomal Dominant Polycystic Kidney Disease Trial in Le Kremlin-Bicêtre (Everolimus, Calcineurin inhibitors maintenance)

                  Completed
                  • Autosomal Dominant Polycystic Kidney Disease
                  • Le Kremlin-Bicêtre, France
                    Bicêtre Hospital
                  Dec 7, 2018

                  Autosomal Dominant Polycystic Kidney Disease Trial in United States (Tolvaptan MR, Tolvaptan IR, Placebo)

                  Completed
                  • Autosomal Dominant Polycystic Kidney Disease
                  • Tolvaptan MR
                  • +2 more
                  • Huntsville, Alabama
                  • +34 more
                  Aug 30, 2018

                  Autosomal Dominant Polycystic Kidney Disease Trial in Kanto Region (OPC-41061)

                  Completed
                  • Autosomal Dominant Polycystic Kidney Disease
                  • Kanto Region, Japan
                    (unnamed)
                  Aug 15, 2018